Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

DABIGATRAN ETEXILATO ADAMED 75 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/DABIGATRAN ETEXILATO ADAMED 75 MG CAPSULAS DURAS EFG

Approved

STANDARD

DABIGATRAN ETEXILATO ADAMED 75 MG CAPSULAS DURAS EFG

Adamed Pharma S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Apr 22, 2024
Approval ID: 66e9bb2b0a7b77ee
Company: Adamed Pharma S.A.
Type: Standard

Approval Details

Approval Id: 66e9bb2b0a7b77ee
Drug Cima Aemps Name: DABIGATRAN ETEXILATO ADAMED 75 MG CAPSULAS DURAS EFG
Register Number: 89513
Holder Company Name: Adamed Pharma S.A.
Marketing Company Name: Adamed Pharma S.A.
Holder Company Detail Path: /organization/adamed-pharma-s-a
Marketing Company Detail Path: /organization/adamed-pharma-s-a
Authorization Date: 2024-04-22
Dosage Form: CÁPSULA DURA
Dose: 75 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Adamed Pharma S.A.
Company Detail Path: /organization/adamed-pharma-s-a

Company Information

Pharmaceutical Company Name: Adamed Pharma S.A.
Country Name: Poland
Website: https://www.adamed.com/

Active Ingredients

DABIGATRAN ETEXILATO MESILATO

86,48 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Apr 22, 2024

Approval ID

66e9bb2b0a7b77ee

Type

Standard

Back to CIMA-AEMPS Approvals